References
- 1. Baigent S.J., Petherbridge L.J., Smith L.P., Zhao Y., Chesters P.M., Nair V.K.: Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek’s disease. J Gen Virol 2006, 87, 769-776.
- 2. Becker Y., Asher Y., Tabor E., Davidson I., Malkinson M., Weisman Y.: Polymerase chain reaction for differentiation between pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDV) and vaccine viruses of MDV-serotypes 2 and 3. J Virol Methods 1992, 40, 307-322.
- 3. Brown A.C., Smith L.P., Kgosana L., Baigent S.J., Nair V., Allday M.J.: Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus. J Virol 2009, 83, 11142-11151.
- 4. Greider C.W., Blackburn E.H.: The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with 2 kinds of primer specificity. Cell 1987, 51, 887-898.
- 5. Jarosinski K.W., Arndt S., Kaufer B.B., Osterrieder N.: Fluorescently tagged pUL47 of Marek's disease virus reveals differential tissue expression of the tegument protein in vivo. J Virol 2012, 86, 2428-2436.
- 6. Jarosinski K.W., Osterrieder N.: Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission. J Virol 2012, 86, 7896-7906.
- 7. Kaufer B.B., Arndt S., Trapp S., Osterrieder N., Jarosinski K.W.: Herpesvirus telomerase RNA (vTR) with a mutated template sequence abrogates herpesvirusinduced lymphomagenesis. PLoS Pathog 2011, 7, doi: 10.1371/journal.ppat.1002333.
- 8. Kim T., Mays J., Fadly A., Silva R.F.: Artificially inserting a reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of Marek's disease virus (MDV) alters expression of nearby MDV genes. Virus Genes 2011, 42, 369-376.
- 9. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., Koszinowski U.H.: Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Nat Acad Sci USA 1997, 94, 14759-14763.
- 10. Mays J.K., Silva R.F., Kim T., Fadly A.: Insertion of reticuloendotheliosis virus long terminal repeat into a bacterial artificial chromosome clone of a very virulent Marek's disease virus alters its pathogenicity. Avian Pathol 2012, 41, 259-265.
- 11. Nair V.: Evolution of Marek's disease - a paradigm for incessant race between the pathogen and the host. Vet J 2005, 170, 175-183.
- 12. Petherbridge L., Howes K., Baigent S.J., Sacco M.A., Evans S., Osterrieder N., Nair V.K.: Replicationcompetent bacterial artificial chromosomes of Marek’s disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 2003, 77, 8712-8718.
- 13. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K.: Oncogenicity of virulent Marek’s disease virus cloned as bacterial artificial chromosomes. J Virol 2004, 78, 13376-13380.
- 14. Schumacher D., Tischer B.K., Fuchs W., Osterrieder N.: Reconstitution of Marek’s disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein Bnegative MDV-1 mutant. J Virol 2000, 74, 11088-11098.
- 15. Singh S.M., Baigent S.J., Petherbridge L.J., Smith L.P., Nair V.K.: Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus. Res Vet Sci 2010, 89, 140-145.
- 16. Silva R.F., Dunn J.R., Cheng H.H., Niikura M.: A MEQdeleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine. Avian Dis 2010, 54, 862-869.
- 17. Sun A., Petherbridge L., Zhao Y., Li Y., Nair V.K., Cui Z.: A BAC clone of MDV strain GX0101 with REVLTR integration retained its pathogenicity. Chin Sci Bull 2010, 54, 2641-2647.
- 18. Sun A., Xu X., Petherbridge L., Zhao Y., Nair V., Cui Z.: Functional evaluation of the role of reticuloendotheliosis virus long terminal repeat (LTR) integrated into the genome of a field strain of Marek's disease virus. Virology 2010, 397, 270-276.
- 19. Tischer B.K., Schumacher D., Beer M., Beyer J., Teifke J.P., Osterrieder K., Wink K., Zelnik V., Fehler F., Osterrieder N.: A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. J Gen Virol 2002, 83, 2367-2376.
- 20. Trapp S., Parcells M.S., Kamil J.P., Schumacher D., Tischer B.K., Kumar P.M., Nair V.K., Osterrieder N.: A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis. J Exp Med 2006, 203, 1307-1317.
- 21. Witter R.L.: Increased virulence of Marek's disease virus field isolates. Avian Dis 1997, 41, 149-163.